You must meet below conditions to view this content
- I am over the age of 19.
- The products distributed are for medicinal purposes.
by DailyHealthPost Editorial
Marijuana research shows no signs of slowing down. Its latest find? A study presented at the 3rd Congress of the European Academy of Neurology has confirmed that the active compounds in cannabis can reduce the frequency of acute migraine pain. These compounds actually work better than prescription migraine medication and have fewer side effects.
The study involved 127 participants with chronic migraines or cluster headaches. Cluster headaches are characterized by severe headaches that occur on one side of the head, particularly around the eye (1). On the other hand, migraine pain often entails light sensitivity and nausea and affects both sides of your head (2).
The oral medication used in the study contained two cannabis-derived cannabinoids: 19% tetrahydrocannabinol (THC) and 9% cannabidiol (CBD). THC, or course, is psychoactive and creates the famous “high” recreational users crave. It’s also incredibly healing. CBD, on the other hand, isn’t psychoactive and is the best known for treating cancer and managing seizures in epileptic children and adults (3).
The two-phase study began by giving 48 participants suffering from chronic, acute migraines a variety of doses of THC-CBD drug. The group that received a daily dose of 200mg of the drug for three months experienced a 55% decrease in pain. Lower doses also reduced pain, but not to the same extent (4).
The second phase included 79 participants suffering from cluster headaches and well as chronic migraines.Participants suffering from migraines were split into to groups and given either 200mg of the THC-CBD drug or 25 milligrams of amitriptyline. Amitriptyline is a common antidepressant medication also used to treat migraines (5).
On the other hand, headache-afflicted participants were given either the THC-CBD drug or 80 milligrams of verapamil. Verapamil is a calcium channel blocker prescription pharmaceutical given to patients with cluster headaches (6).
In both groups, the THC-CBD medication came on top. For migraines, THC-CBD was slightly better at lowering the frequency of attacks and m reduced migraine pain by 43.5%. For cluster headaches, the THC-CBD medication was also helpful at reducing pain. However, it worked best for participants who had a childhood history of migraines.